Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Pharma
Stada charts strong first half of 2024 as owners weigh options
As Stada's owners continue to weigh their options, the German drugmaker gave a good indication Wednesday of exactly what it can bring to the table.
Fraiser Kansteiner
Aug 28, 2024 4:25pm
Galderma kicks off the process for $2.6B IPO
Mar 13, 2024 12:17pm
Galderma raises $1B through private placement
Jun 27, 2023 11:02am
As IPO nears, J&J eyes $40B valuation for Kenvue: WSJ
Apr 24, 2023 2:55pm
J&J's consumer health unit Kenvue files for IPO
Jan 6, 2023 11:28am
